NCT00144261View on ClinicalTrials.gov

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 1, 2003

Primary Completion Date

December 1, 2006

Conditions
HIV InfectionsMetabolism, Lipids
Interventions
DRUG

nevirapine

Trial Locations (3)

Unknown

1100.1426.01 Academic Medical Centre, Amsterdam

1100.1426.02 Onze Lieve Vrouwe Gasthuis, Amsterdam

1100.1426.44001 Boehringer Ingelheim Investigational Site, London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY